Global Artificial Intelligence in Diabetes Management Market Size and Forecast 2024-2033|Alphabet Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic PLC, Dexcom Inc.,

The Artificial Intelligence in Diabetes Management Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Artificial Intelligence in Diabetes Management Market:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report

According to The Business Research Company’s Artificial Intelligence in Diabetes Management Global Market Report 2024, The artificial intelligence in diabetes management market size has grown exponentially in recent years. It will grow from $0.48 billion in 2023 to $0.63 billion in 2024 at a compound annual growth rate (CAGR) of 31.6%.  The  growth in the historic period can be attributed to data accumulation, rising diabetes cases, healthcare cost pressures, early ai applications.

The artificial intelligence in diabetes management market size is expected to see exponential growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 31.7%.  The growth in the forecast period can be attributed to ai-powered decision support systems, telemedicine integration, genomic data utilization, regulatory support. Major trends in the forecast period include advancements in wearable technology, personalized treatment plans, continuous glucose monitoring advances, ai-powered risk prediction, behavioral modification support.

The rising prevalence of diabetes is expected to propel artificial intelligence in the diabetes management market going forward. Diabetes occurs when the blood glucose, or blood sugar, is too high. Diabetes is a condition that causes various conditions such as eye problems, heart attacks and strokes, kidney problems, and others. Artificial intelligence is used to manage diabetes as it provides information about high or low blood sugar levels in a diabetic patient and collects data that has not been used previously. For instance, in December 2021, according to the International Diabetes Federation, a US-based intergovernmental organization, diabetes affected 537 million adults (20–79 years old) in 2021, and it is predicted that the number will climb to 643 million people by 2030 and 783 million by 2045. Therefore, the rising prevalence of diabetes is driving the growth of artificial intelligence in the diabetes management market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12593&type=smp

The artificial intelligence in diabetes management market covered in this report is segmented –

1) By Device: Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices, Other Devices

2) By Techniques: Case-Based Reasoning, Intelligent Data Analysis

3) By End-Use: Hospitals, Clinics, Home Care Settings, Research Institutes

Technological advancements are a key trend gaining popularity in the artificial intelligence in diabetes management market. Major companies operating in the artificial intelligence in diabetes management market are focused on innovating new and advanced technological solutions to sustain their position in the market. For instance, in October 2022, Dr. Mohan’s Diabetes Specialties Center, an India-based diabetes specialty hospital chain, launched an innovative artificial intelligence-enabled platform for precision diabetes care with the 3D Initiative. The first of the three Ds is DIA, an AI-powered chatbot that can help individuals through pre-recorded digital interactions. The second is DIALA, a user-friendly smartphone app for patients; the last is DIANA, a medical app for precise diabetic care. According to the company, it is supported by the most advanced Total Experience (TX) Automation Platform, which powers an AI-enabled virtual assistant that interacts with patients on platforms such as Facebook Messenger, WhatsApp, Google Business Message, and the web.

The artificial intelligence in diabetes management market report table of contents includes:

1. Executive Summary

2. Artificial Intelligence in Diabetes Management Market Characteristics

3. Artificial Intelligence in Diabetes Management Market Trends And Strategies

4. Artificial Intelligence in Diabetes Management Market – Macro Economic Scenario

5. Global Artificial Intelligence in Diabetes Management Market Size and Growth

.

.

.

26. South America Artificial Intelligence in Diabetes Management Market

27. Brazil Artificial Intelligence in Diabetes Management Market

28. Middle East Artificial Intelligence in Diabetes Management Market

29. Africa Artificial Intelligence in Diabetes Management Market

30. Artificial Intelligence in Diabetes Management Market Competitive Landscape And Company Profiles

Top Major Players:

• Alphabet Inc
• F. Hoffmann-La Roche AG
• Abbott Laboratories
• Medtronic PLC
• Dexcom Inc

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model